This study will evaluate the food effect on the pharmacokinetics of DA-5223 in healthy adult subjects
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
once a day
once a day
CHA Global Clinical Trials Center
Seongnam-si, Gyeonggi-do, South Korea
AUC-last
Area under the plasma concentration-time curve up to the last measurable concentration
Time frame: 0~12 hours
Cmax
Peak Plasma Concentration
Time frame: 0~12 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.